Bacteriophages Market Is Anticipated To Reach US$ 72.1 Million By 2032
The population’s changing and hurried lifestyles are to blame for the increase in the frequency of gastrointestinal complaints. The preservation of good stomach bacteria by bacteriophages is known to improve digestion, maintain regular bowel motions, and lessen intestinal inflammation. Customers therefore readily accept Bacteriophage as pre/probiotic dietary supplements.
Download Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=5558?PS
Users who have bacterial infections have been in great demand for Bacteriophage. Producing bacteriophage dietary supplements for a healthy gut has helped major industry players maintain a dominant position in the healthcare market. The usage of bacteriophage therapy among patients has been greatly influenced by rising rates of dysentery and UTIs.
From 2017 to 2021, end users used phage probiotics at a compound annual growth rate of 3.5%.
Key Companies Profiled
- Life Extension
- Arthur Andrew Medical
- ADM.
- Biochimpharm
- Micreos Human Health
- Designs for Health
- Armata Pharmaceuticals Inc.
- The biostation
- Probiotic America
- Microgen
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=5558?PS
By 2032, the European bacteriophage market is anticipated to generate US$28.5 million.
Demand for preventative healthcare has increased as consumers’ preferences for a healthy lifestyle have changed. Additionally, it has inspired manufacturers to create new, useful goods that support healthy lifestyle maintenance in a variety of ways in response to customer demands. Consequently, the bacteriophage sector gains access to a big market.
The research also includes profiles of the Bacteriophage industry’s goods, sales, returns, competitive landscape, market structure, industry drivers, and key business challenges. The study calculates the market’s current growth rate, projected future growth, and the key drivers that will affect that growth in 2022. The research also anticipates sales for the years 2022 to 2032
Segmentation of Bacteriophage Industry Research
- By Product Type :
- Phage Probiotics
- Phage Therapeutics
- By Route of Administration :
- Oral
- Topical
- Others
- By Application :
- Gastroenterology
- Respiratory Infections Treatment
- Skin Infection Treatment
- Wound Prophylaxis
- Urogenital Infection Treatment
- Others
- By Distribution channel :
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Get Full Access of Complete Report: https://www.factmr.com/checkout/5558
Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
Xherald
